Form 4 for PACB PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Accepted 2022-08-26 00:00:00 ET · period of report 2022-08-25 · accession 0001299130-22-000108 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-26 | 2022-08-25 | PACB | Van Oene Mark | See Remarks | A - Grant | $0.00 | +300.0K | 667.5K | +82% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-25 | A | A | 300,000 | $0.00 | 667,528 | D | — | — | (F1) Each share is represented by a Restricted Stock Unit ("RSU"). The RSUs will vest in equal annual installments on August 15th of each of 2023, 2024, 2025, and 2026, provided that the Reporting Person continues to serve through each vesting date. (F2) Includes 1,508 shares purchased on September 1, 2021 and March 1, 2022 under the Company's 2010 Employee Stock Purchase Plan. |